Home » Topics » Briefs » Other news to note

Other news to note
RSS

Shire outlines progress of first quarter 2014

May 8, 2014

Bayer and Merck & Co. sign consumer business deal and collaborate on sGC modulators

May 7, 2014

Sanofi reports achievements of first quarter 2014

May 7, 2014

Bristol-Myers Squibb updates pipeline progress of first quarter 2014

May 6, 2014

Fibrotech acquired by Shire

May 5, 2014

Forest Laboratories to acquire Furiex Pharmaceuticals

May 2, 2014

AstraZeneca offers overview of first quarter 2014

May 2, 2014

Bristol-Myers Squibb acquires iPierian

April 30, 2014

Meda rejects Mylan merger proposal

April 30, 2014

AstraZeneca declines latest offer from Pfizer

April 30, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...